Bio-Techne Corp. buy melinda
Start price
21.11.17
/
50%
€7.45
Target price
30.11.17
€7.61
Performance (%)
2.23%
End price
30.11.17
€7.62
Summary
This prediction ended on 30.11.17 with a price of €7.62. The BUY prediction by melinda finished with a performance of 2.23%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bio-Techne Corp. | 5.357% | 5.357% | -19.178% | -21.333% |
| iShares Core DAX® | 0.721% | 4.566% | 24.333% | 64.224% |
| iShares Nasdaq 100 | -0.413% | 1.884% | 8.848% | 107.611% |
| iShares Nikkei 225® | 3.500% | 7.196% | 24.030% | 57.276% |
| iShares S&P 500 | 0.489% | 2.436% | 6.048% | 67.009% |
Comments by melinda for this prediction
In the thread Bio-Techne Corp. diskutieren
Biotechnologie und Medizintechnik SecteurRecherche Agenda 30/11 Präsentation
Bio-Techne Corp. engagiert in der Entwicklung, Herstellung und Verkauf von Biotechnologie Reagenzien und Instrumente für die Forschung und markets.It klinische Diagnose ist in drei Segmente sind: Biotechnologie, Protein-Plattformen, und Diagnostics.